Andromeda Metals Limited Overview
Andromeda Metals is an Adelaide-based, ASX-listed industrial-minerals developer whose value rests almost entirely on the 100%-owned Great White Project (GWP) on South Australia's Eyre Peninsula — a fully permitted, high-grade kaolin and halloysite-kaolin deposit with a planned 28-year mine life and staged capacity of up to 330,000 tonnes per annum of refined kaolin. The company's commercial thesis is to supply premium ceramic-grade kaolin (Great White CRM™) and a low-carbon concrete additive (Great White HRM™) into a market it characterises as structurally under-supplied, underpinned by binding offtakes including with global trader Traxys. A second, potentially larger leg is a proprietary process for producing 4N high-purity alumina (HPA) from Great White kaolin, now at pilot-plant stage. Andromeda has not yet reached a final investment decision: its cash balance is thin, its Middle East cornerstone equity process has stalled, and its market value trades at a steep discount to book.
What the company does
Andromeda is a mineral exploration and development company. It does not yet produce or sell product at commercial scale and reports no operating revenue. Its activities fall into three buckets:
-
Great White Project (GWP) — kaolin development. Construction-ready mine and wet-processing plant near Poochera / Streaky Bay, South Australia, designed to mine kaolinised granite, refine it on site, and ship refined kaolin products to ceramics and concrete customers. All key permits are in place, feasibility studies are complete, and offtakes cover Stage 1A+ volumes.
-
High Purity Alumina (HPA) Project. A proprietary acid-leach-type flowsheet (details not fully disclosed) converting Great White kaolin into 4N (≥99.99%) alumina, with laboratory purity of 99.9985% reported and a continuous pilot plant commissioned in July 2026. Potential co-products include amorphous silica and gallium.
-
Regional exploration and portfolio. A 51% interest in the Eyre Kaolin joint venture (acquired July 2024), the Mount Hope kaolin project, and legacy holdings, alongside a history of divesting non-core gold and copper assets.
Business and revenue model (planned)
| Revenue stream | Model | Status (Oct 2026) |
|---|---|---|
| Refined kaolin (Great White CRM™, KCM™90) | Product sales under multi-year offtake (FOB/CFR), priced per wet/dry metric tonne | Pre-production; offtakes signed for Stage 1A+ |
| Great White HRM™ (metakaolin-type concrete additive) | Product sales under conditional offtakes | Pre-production; conditional agreements |
| Industrial sand co-product | Bulk product sales | Pre-production |
| HPA (4N) | Product sales to LED, battery separator, semiconductor and specialty-ceramic customers | Pilot stage; commercial samples targeted 2H 2026 |
| Co-products (amorphous silica, gallium) | Potential product sales | Under evaluation in pilot program |
| Licensing / services | None disclosed | — |
The current mix is therefore 100% prospective product revenue; there is no service, subscription or licensing revenue. Reported "income" in recent years consists of interest, R&D tax incentive-related items, sample sales and other sundry income (for example, total income of about A$0.76m in FY2025 per the FY2025 Annual Report; A$0.53m in the six months to 31 December 2024; A$0.72m in the six months to 31 December 2023).
Value-chain position
Andromeda sits at the upstream end of the industrial-minerals chain: mining, beneficiation (wet processing to remove quartz and impurities) and, prospectively, downstream chemical refining (HPA). Its customers are processors and manufacturers — tile, sanitaryware and porcelain makers; concrete and cement product producers; and, for HPA, makers of sapphire substrates, lithium-ion battery separator coatings, phosphors and semiconductor components. Traxys, a commodity trading house, acts as offtaker and marketing intermediary for parts of Asia, India and the Middle East.
Customer types and end-markets
| End-market | Product | Demand driver |
|---|---|---|
| Premium ceramics (porcelain tiles, sanitaryware, tableware) | Great White CRM™, KCM™90 | Whiteness/brightness, low iron and titanium, plasticity; long-term depletion of traditional high-quality kaolin sources (company view) |
| Concrete / cement | Great White HRM™ | Decarbonisation of concrete via supplementary cementitious materials |
| Industrial sand | Sand co-product | Construction and industrial uses |
| HPA end-uses | 4N HPA | LED sapphire, Li-ion battery separator coatings, semiconductors |
Company's own description vs. independent characterisation
The company describes its ambition as becoming "The Great White Mineral Company" and a leading global supplier of industrial minerals, with the GWP described as a high-grade, development-ready, Tier 1 kaolin asset (FY2024 and FY2025 Annual Reports; company materials).
Independent characterisation: Andromeda is a micro-cap, single-asset, pre-FID development company with a technically de-risked but unfunded project. The key constraint is not geology or permitting but capital: the company has repeatedly come close to financing (A$75m Merricks Capital credit approval in June 2025; a Middle East cornerstone investor in final negotiations in early 2026) without closing. The HPA strategy is strategically logical — it lifts potential value per tonne of kaolin dramatically — but it also adds a second capital requirement (~A$155m pre-production capex per the 2025 Scoping Study) to a company with ~A$3m of cash at 30 June 2026.
Strategy
Stated strategy (themes from FY2024–FY2025 Annual Reports and 2026 updates)
-
Develop the Great White Project in stages (Stage 1A+ 100ktpa → Stage 1B +110ktpa → Stage 2 +120ktpa; up to 330ktpa refined kaolin), capturing value through on-site refining rather than direct-shipping ore.
-
Target premium, high-value markets (ceramics, low-carbon concrete) where Great White's quality commands top-of-range kaolin pricing.
-
Commercialise HPA as a critical-mineral growth leg, creating a new supply chain independent of traditional bauxite/aluminium routes.
-
Fund development via a mix of senior debt (Merricks), strategic/cornerstone equity at asset level, offtaker support (Traxys subordinated facility) and government incentives (R&D Tax Incentive; potential critical minerals grants).
-
Maintain capital discipline: cost reductions of ~A$3m identified in 2026; postponement of non-essential exploration.
Initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Merricks Capital A$75m senior debt facility | Credit approval 4 Jun 2025 | Staged drawdown; senior security over project; 400m warrants at a 10% premium to development equity price | Subject to equity funding and documentation; not drawn |
| Global cornerstone equity process | 2025–2026 | Middle East-based institution; asset-level investment across GWP and HPA; due diligence complete | Disrupted by Middle East conflict (Q1 2026); alternatives assessed in parallel |
| Stage 1A+ detailed engineering and plant optimisation | 2,025 | Plant design optimised for product quality and cost; production stages consolidated to lift capacity; capex review showed no material change | Complete |
| GWP early works | Oct 2025 – Jul 2026 | Site clearance, topsoil stockpiling, mine access track, fencing, stormwater pond, plant pad bulk earthworks, drill-and-blast trial, grade-control drilling, long-lead equipment transport | Complete; remaining funding requirement ~A$40m (April 2026 estimate) |
| HPA Scoping Study | 18 Sep 2025 | 10ktpa 4N HPA; NPV10 post-tax A$1.01bn | Complete |
| HPA pilot plant | Jun–Jul 2026 | Continuous flowsheet; co-product evaluation | Commissioned; testwork underway |
| HPA commercial samples and marketing | 2H 2026 | 4N samples for customer qualification | Targeted |
| HPA Pre-Feasibility Study | 2H 2026 | Subject to funding; supported by Sep 2026 SPP | Planned |
| Cost-reduction program | Mar 2026 | ~A$3m savings across early works, procurement and admin | Implemented |
| ESG / low-carbon positioning | Ongoing | HRM™ for concrete decarbonisation; lower-carbon HPA claim | Ongoing |
Medium-term targets / guidance
-
Stage 1A+ FID: targeted once funding is secured (earlier aspiration of construction in 2H 2025 has slipped).
-
Total Stage 1A+ funding target: ~A$90m plus financing costs, interest and reserves (including ~A$84m capex), per Invest SA project profile; early works have since reduced the remaining requirement to ~A$40m (company, April 2026 — the basis of this figure, e.g. net of debt, should be checked).
-
GWP economics (May 2024 expansion case): post-tax NPV8 A$763m; IRR 43%; average EBITDA ~A$140m p.a. at full staged capacity.
-
No formal earnings guidance. One analyst (as aggregated by Simply Wall St) had projected a loss in FY2026 and a profit of ~A$34m in FY2027 — now clearly stale given the funding delay.
Products & Services
All products are pre-commercial. Pricing models are offtake-based; specific prices are not publicly disclosed beyond the statement that Traxys year 1–2 prices are consistent with 2023 DFS assumptions.
Kaolin products (Great White Project)
Great White CRM™ (Ceramic Raw Material)
-
Description: Refined, wet-processed kaolin for premium ceramics; the core volume product for Stage 1A+.
-
Key specifications: High whiteness and fired brightness, low iron/titanium; marketed for its ability to partially displace zircon opacifiers in ceramic glazes/bodies (company claims).
-
Target customers: Porcelain tile, sanitaryware and tableware producers in Asia, the Middle East, India and Europe.
-
Offtakes: Binding agreements including Traxys Europe S.A. (July 2024) — 25,000 wmt in year 1 and 40,000 wmt in year 2, with year-3-onward volumes at higher levels (±10% at Traxys' option); pricing upside on Traxys' on-sales shared equally; prices from year 3 subject to annual negotiation. An earlier binding agreement contemplated 115,000 tonnes of CRM™ over five years. A Chinese distributor agreement was referenced for the China market, with India and Middle East sales of CRM™ managed by Traxys.
-
Launch: Not yet launched; production targeted after FID.
Great White KCM™90
-
Description: High-specification kaolin ceramic product (core product per 2023 strategy review).
-
Offtake: 5,000 tonnes in the first year of production under a signed agreement (Half-Year Report, Dec 2023).
-
Target customers: High-end ceramics manufacturers.
Great White HRM™
-
Description: A halloysite-kaolin-derived reactive additive designed to help decarbonise concrete (supplementary cementitious material); also historically marketed as a rheology modifier.
-
Offtake: Conditional agreements for 5,000–10,000 wmt p.a. into concrete applications (subject to a market acceptance condition precedent in favour of the buyer).
-
Target customers: Concrete and cement product manufacturers.
Industrial sand co-product
-
Description: Quartz sand separated during wet processing.
-
Target customers: Construction and industrial users.
-
Commercial terms: Not publicly disclosed.
High Purity Alumina (HPA)
4N HPA (≥99.99% Al₂O₃)
-
Description: Produced from Great White kaolin via a proprietary process the company describes as lower-cost and lower-carbon than incumbent routes; the company states it can tailor morphology and product form.
-
Key capabilities: Lab purity 99.9985%; continuous pilot plant commissioned July 2026; commercial samples targeted for customer evaluation in 2H 2026.
-
Scoping Study (Sept 2025): 10,000tpa HPA using ~30,000tpa of kaolin feedstock (sourced arm's-length from GWP); 24-year life; pre-production capex ~A$155m (~A$159m total with ~30% contingency per media summary); capital intensity ~A$15,459/t capacity; operating cost ~A$4,718/t (excluding silica by-product credits); NPV10 A$1.48bn pre-tax / A$1.01bn post-tax; post-tax IRR ~69%; a 20% change in HPA price moves NPV by ~26%.
-
Target customers: LED/sapphire, Li-ion battery separator coating, semiconductor and specialty materials producers.
Amorphous silica (potential co-product)
- Being evaluated in the pilot program; the company has signalled possible reclassification from by-product to high-value co-product.
Gallium (potential co-product)
- Recovery potential under evaluation, framed against Chinese export controls on gallium (imposed from 2023).
Halloysite / nanotechnology (legacy R&D)
- Halloysite nanotube applications (carbon capture, hydrogen storage, environmental remediation, slow-release fertilisers) were promoted in 2021–2023, including through the Natural Nanotech entity and a research agreement on carbon capture referenced in the FY2023 Annual Report. These are not currently central to the commercial plan.
Financial Narrative
Source: S&P Global Market Intelligence data (via StockAnalysis.com), cross-checked to FY2023–FY2025 Annual Reports and half-year reports where available. FY2026 figures derived from S&P data incorporating the H1 FY2026 half-year report (lodged 16 March 2026) and FY2026 annual results (released c. 6 October 2026). All figures A$ millions unless noted.
Income statement
Notes: FY2026 EPS is S&P's rounded A$-0.02; Simply Wall St reported A$-0.023 on a trailing basis to December 2025. Half-year net results: H1 FY2025 -2.34; H2 FY2025 -3.70; H1 FY2026 -101.58; H2 FY2026 -3.46. Margins (gross, operating, EBITDA, net) and revenue CAGR are not meaningful at zero revenue. Earlier-year EBITDA figures differ slightly by provider (TipRanks shows FY2023 -10.58 and FY2022 -8.30), reflecting differing treatment of exploration write-offs.
Commentary. Underlying cash operating losses have trended down steadily — EBITDA improved from about -A$8.9m in FY2023 to about -A$5.6m to -A$6.2m in FY2025–FY2026 — reflecting cost discipline as the company shifted from a large corporate team building for production to a lean, financing-focused structure. The dominant feature of FY2026 is a ~A$99m non-cash charge booked in the half to 31 December 2025, which S&P classifies within depreciation, amortisation and impairment. Property, plant and equipment (which in S&P's taxonomy includes capitalised exploration, evaluation and development assets) fell from A$150.6m at 30 June 2025 to A$54.4m at 31 December 2025, and equity fell from A$157.9m to A$69.6m. Analytically, the write-down brings book value closer to market value but does not change the project's physical or permitting status.
Balance sheet
Notes: FY2026 share count is the 31 December 2025 figure (4,621m); additional small issues in January and April 2026 are possible. The September 2026 SPP added ~516m shares, taking the total to ~5.14bn. Interim balance at 31 December 2025: cash A$10.06m, PP&E A$54.35m, total assets A$71.66m, equity A$69.62m.
Commentary. The balance sheet is debt-free apart from small office/equipment leases, which is a genuine strength, but liquidity is now critical: cash fell to ~A$3.2m at 30 June 2026 against an annual free-cash outflow of ~A$14m in FY2026. The A$3.04m raised in September 2026 provides only a few months of runway at FY2026 burn rates, although management has cut ~A$3m of costs and completed most early-works spending. The equity base was cut by more than half by the H1 FY2026 write-down.
Cash flow
Notes: Capex derived as FCF minus OCF. FY2023 OCF shown by TipRanks as -8.78 vs -9.13 (S&P) — discrepancy noted. FY2026 net change in cash computed from balance sheet (7.14 to 3.20). Half-year FCF: H1 FY2026 -6.27; H2 FY2026 -7.92.
Commentary. Capital expenditure rose in FY2026 (to ~A$9.0m) as early works, bulk earthworks for the Stage 1A+ plant pad, a drill-and-blast program, grade-control drilling and transport of long-lead items were executed, along with the HPA pilot plant. R&D tax refunds (A$2.34m for FY2024, received early 2025; A$1.66m for FY2025, received May 2026) are a recurring non-dilutive cash source but are small relative to burn.
Ratios
Notes: FY2022–FY2025 ROE/ROA computed on average equity/assets from the tables above; FY2026 ROE, ROA and current ratio as reported by S&P Global. ROIC (S&P, FY2026): -58.6%. Net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle: not meaningful (net cash, no revenue, negligible interest).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Results by Segment and Revenue by Segment (%)
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Mineral exploration & development, Australia — operating revenue (AUD Mn) | 0 | 0 | 0 |
Mineral exploration & development, Australia — pre-tax result (AUD Mn) | -7.27 | -6.04 | -105.03 |
Share of total revenue (%) | 100 | 100 | 100 |
Unit / Project Details
| Unit / project | Ownership | Contents | Stage |
|---|---|---|---|
Great White Project (GWP) | 100% | Great White deposit; three mining tenements and three exploration tenements; Streaky Bay Pilot Plant; Stage 1A+ plant pad | Construction-ready; early works complete; awaiting FID funding |
HPA Project | 100% (company); cornerstone discussions contemplated asset-level investment | Proprietary HPA flowsheet; pilot plant; 2025 Scoping Study | Pilot testwork; PFS planned subject to funding |
Eyre Kaolin Project (JV) | 51% (acquired July 2024) | Regional kaolin tenements | Exploration; sample analysis postponed (June 2026 quarter) for cost reasons |
Mount Hope Kaolin Project | Interest per company reports | Kaolin exploration | Exploration |
Legacy / divested assets | Divested or non-core | Wudinna gold (sold to Cobra Resources), Moonta copper-gold, Drummond epithermal gold (Qld) | Divestment program |
Income Statement and Share Count (m)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating revenue (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Gross profit (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
SG&A expense (AUD Mn) | 5.38 | 7.45 | 6.63 | 4.99 | — |
R&D expense (AUD Mn) | 0.85 | 2.84 | 0.82 | 0.73 | — |
Operating income / EBIT (AUD Mn) | -8.41 | -9.89 | -7.54 | -5.94 | -105.28 |
EBITDA (AUD Mn) | -7.88 | -8.94 | -6.45 | -5.62 | -6.18 |
D&A and impairment charges (AUD Mn) | 0.52 | 0.94 | 1.09 | 0.32 | 99.10 |
Pre-tax income (AUD Mn) | -8.73 | -9.46 | -7.27 | -6.04 | -105.03 |
Net income (AUD Mn) | -8.73 | -9.46 | -7.27 | -6.04 | -105.03 |
Weighted avg shares, basic (m) | 2,662 | 3,110 | 3,110 | 3,418 | — |
EPS basic (A$ cents) | -0.33 | -0.30 | -0.23 | -0.18 | -2.0 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet and Share Count (m)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash & equivalents (AUD Mn) | 32.85 | 15.30 | 5.44 | 7.14 | 3.20 |
Total current assets (AUD Mn) | 34.35 | 19.89 | 6.14 | 8.79 | — |
PP&E incl. capitalised project assets (AUD Mn) | 139.50 | 144.84 | 149.94 | 150.59 | — |
Total assets (AUD Mn) | 174.22 | 165.03 | 158.07 | 160.21 | — |
Total debt — leases only (AUD Mn) | 0.85 | 0.73 | 0.58 | 0.37 | 0.15 |
Short-term debt / current leases (AUD Mn) | 0.17 | 0.20 | 0.22 | 0.21 | — |
Long-term debt / non-current leases (AUD Mn) | 0.68 | 0.53 | 0.37 | 0.15 | — |
Net cash (AUD Mn) | 32.01 | 14.57 | 4.85 | 6.78 | 3.05 |
Total liabilities (AUD Mn) | 3.03 | 2.87 | 3.19 | 2.27 | — |
Shareholders' equity (AUD Mn) | 171.19 | 162.16 | 154.88 | 157.93 | 66.20 |
Goodwill & intangibles (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Working capital (AUD Mn) | 32.03 | 17.65 | 3.43 | 6.86 | 3.54 |
Shares outstanding at period end (m) | 3,106 | 3,108 | 3,108 | 3,813 | 4,621 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -5.14 | -9.13 | -5.05 | -4.77 | -5.17 |
Capital expenditure (AUD Mn) | -5.11 | -8.60 | -7.90 | -4.28 | -9.01 |
Free cash flow (AUD Mn) | -10.25 | -17.73 | -12.95 | -9.05 | -14.18 |
Investing cash flow (AUD Mn) | -9.83 | -8.19 | -4.56 | -1.40 | — |
Financing cash flow (AUD Mn) | 42.92 | -0.22 | -0.25 | 7.87 | — |
Net change in cash (AUD Mn) | 27.95 | -17.55 | -9.86 | 1.71 | -3.94 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | -9.30 | -5.68 | -4.59 | -3.86 | -93.72 |
ROA (%) | -9.09 | -5.58 | -4.50 | -3.80 | -57.66 |
Current ratio (x) | 14.81 | 8.88 | 2.26 | 4.55 | 3.60 |
Debt / equity (x) | 0.005 | 0.005 | 0.004 | 0.002 | 0.002 |
Geographic Revenue
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia — operating revenue (AUD Mn) | 0 | 0 | 0 |
Asia-Pacific ex-Australia — operating revenue (AUD Mn) | 0 | 0 | 0 |
EMEA — operating revenue (AUD Mn) | 0 | 0 | 0 |
Americas — operating revenue (AUD Mn) | 0 | 0 | 0 |
Capital Markets
| Measure | Value | Date / source |
|---|---|---|
Current price | A$0.006 | 7 Oct 2026 (S&P via StockAnalysis) |
52-week change | -68.4% | 7 Oct 2026 (S&P) |
1-year change (alternative) | +28.6% | Simply Wall St, early 2026 snapshot (different base date) |
3-year change | -81.6% | Simply Wall St, early 2026 snapshot |
5-year change | -96.9% | Simply Wall St, early 2026 snapshot |
5-year beta | 2.09 | S&P |
Average daily volume (20-day) | ~3.6m shares | S&P |
Share Count (m) and Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Shares outstanding at year end (m) | 3,106 | 3,108 | 3,108 | 3,813 | 4,621 |
Equity raised, approx. (AUD Mn) | 43 | 0 | 0 | 8 | 16 |
Valuation Multiples
| Multiple | Andromeda | Peer comparison |
|---|---|---|
P/E | n/m (loss) | n/m |
EV/EBITDA | n/m (negative EBITDA) | n/m |
EV/Sales | n/m | n/m |
P/B | 0.47x (on post-write-down equity of A$66.2m) | — |
EV vs. study NPV | EV ~A$27.8m vs GWP post-tax NPV8 A$763m (May 2024) — ~4% of study NPV | Typical pre-FID developers trade at a fraction of NPV; the discount here is extreme |
Analyst Conclusions
Management guidance
-
HPA: complete pilot testwork, produce commercial 4N samples for customer evaluation in 2H 2026, and progress a PFS subject to funding.
-
GWP: secure cornerstone equity (or alternatives) to reach FID for Stage 1A+; Merricks A$75m facility remains credit-approved but conditional.
-
Corporate: appoint a permanent CEO; maintain ~A$3m cost savings.
-
No quantitative earnings, production or capex guidance for FY2027.
Consensus
No reliable consensus exists. A previously aggregated forecast of a ~A$34m profit in FY2027 should be disregarded as stale given that FID has not occurred.
Bull case
-
Deep value vs. de-risked asset: EV of ~A$28m against a permitted project with post-tax NPV8 of A$763m and completed early works implies large re-rating potential if funding closes.
-
HPA could transform the equity story: A successful pilot and customer qualification of a low-cost (~A$4,718/t opex) kaolin-to-HPA process, plus gallium/silica credits, could attract strategic capital at the asset level independent of the kaolin project.
-
Funding architecture largely built: Debt is credit-approved, offtakes are signed, R&D incentive Advance Finding is in place; the missing piece is a single equity cheque (~A$40m remaining requirement per April 2026 update).
Bear case
-
Financing has failed repeatedly: Construction was targeted for 2H 2025; by October 2026 there is still no FID, and the cornerstone investor has been hit by regional conflict.
-
Existential dilution: With ~A$3m of cash post-June 2026 plus A$3m raised in September and annual burn above A$10m, further raises at sub-cent prices are likely, eroding any eventual upside per share.
-
Write-down signals scepticism: The ~A$99m impairment and P/B of 0.47x suggest both accountants and markets doubt the recoverability of historical capitalised costs on current funding prospects.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing |
|---|---|
| September 2026 quarterly report (cash, funding status) | Late Oct 2026 |
| 2026 AGM (board composition, remuneration votes) | Nov 2026 (expected) |
| Commercial 4N HPA samples delivered to customers | 2H 2026 |
| Permanent CEO appointment | Pending |
| Cornerstone equity agreement / alternative funding | Unscheduled |
| Merricks facility documentation and financial close | Contingent on equity |
| HPA PFS commencement and results | 2H 2026 start; results likely 2027 |
| Gallium/silica co-product results from pilot | 2H 2026 |
| Further capital raises and dilution | Likely within 6 months |
| Going-concern language in FY2026 audit report | Released with Annual Report |
Analyst verdict
Andromeda Metals presents a stark divergence between asset quality and corporate condition. On the asset side, the Great White Project is about as de-risked as a pre-FID industrial-minerals project can be: tenure and approvals are in place, feasibility work has been iterated through a DFS and an expansion study, site early works are finished, long-lead equipment is on site, and Stage 1A+ volumes are fully covered by binding offtakes including a global trading house. The HPA leg adds credible, if unproven, upside, and the July 2026 pilot commissioning is a genuine technical step forward.
On the corporate side, however, the company is fragile. Cash at 30 June 2026 was roughly A$3.2m, free cash outflow was about A$14m in FY2026, and the September 2026 SPP raised only A$3m. The ~A$99m write-down in the December 2025 half signals that management and auditors could no longer support historical carrying values on current funding visibility. The board is small, the chief executive role has been filled on an acting basis for two years, and the cornerstone investor on which FID depended has been disrupted by events entirely outside the company's control.
The equity therefore behaves like a binary option on a funding event. If a cornerstone or strategic partner commits at the asset level, the Merricks facility, warrants and offtakes can fall into place quickly and the market value — currently around 4% of the 2024 study NPV — could re-rate sharply, though existing shareholders would likely be diluted at the asset or parent level. If funding does not materialise within the next two to three quarters, the company faces continued sub-cent raises, possible asset-level sell-downs on weak terms, or a strategic transaction at a low valuation.
Verdict: High-risk, speculative special situation. Monitor the September quarterly, HPA sample feedback and any funding announcement; fundamentals do not support a position without clear evidence that FID financing is in hand.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles / background | Education |
|---|---|---|---|---|
Sue-Ann Higgins | Executive Chair | Director since Feb 2024; Executive Chair since Sep 2024 | Senior resources executive; leads board through CEO search and financing | — |
Sarah Clarke | Acting CEO; General Counsel & Company Secretary | GC/CoSec since Jan 2023; Acting CEO since Sep 2024 | Corporate/resources lawyer | LLB (Hons), BSc, Grad Cert (Applied Finance & Investment) |
Keith Pollocks | Chief Financial Officer | From 20 Jul 2026 | 30+ years in finance leadership across SolGold, Kasbah Resources, Newcastle Coal Infrastructure Group, MMG, LyondellBasell, Shell and Lloyds Bank; project finance and capital markets experience across ASX, HKEX, TSX and LSE-listed companies | — |
Joseph (Joe) Ranford | — | From Apr 2020 | GM Angas Zinc Mine (Terramin), COO Otso Gold, GM Extension Hill (MGX), COO Compass Gold, GM Australian Ops (Crocodile Gold); AusIMM member | MBA (University of Adelaide) |
Board of Directors
| Name | Role | Independence | Appointed / notes |
|---|---|---|---|
Sue-Ann Higgins | Executive Chair | Not independent (executive) | 2024 |
Mick Wilkes | Non-executive Director (former Chair) | — | Former Chair; waived director fees from Sep 2024 until project financing secured |
Jean-Dominique Sorel | Non-executive Director | Not independent in substance given Traxys alignment (verify) | Industrial minerals veteran (45+ years); appointment linked to Traxys partnership |
Miguel Galindo | Non-executive Director | — | Appointed 16 Jan 2025 |
Executive Leadership Team by Person
| Person | Total | Source / year |
|---|---|---|
Executive Chair (Higgins) | ~A$149,690 | Simply Wall St (FY2025 basis) |
Other NEDs | Reported totals of ~A$16.7k, ~A$99.3k and ~A$177.2k (names not mapped) | Simply Wall St |
Major Shareholders
| Category | Stake | Source |
|---|---|---|
Insiders | ~7.10% | S&P Global (Oct 2026) |
Institutions | ~1.34% | S&P Global (Oct 2026) |
Free float | ~4.63bn shares | S&P Global |
Acting CEO direct holding | ~0.02% | Simply Wall St |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Listing | Positioning vs. Andromeda |
|---|---|---|---|
Kaolin (global) | Imerys | Euronext Paris (NK) | Global leader in performance minerals and kaolin; vastly larger, integrated, producing |
Kaolin (global) | Sibelco | Private (Belgium) | Major global industrial minerals producer incl. ceramic clays and kaolin |
Kaolin (US) | KaMin / CADAM (acquired BASF's kaolin business 2022) | Private | Large US/Brazil kaolin producer |
Kaolin (US) | Thiele Kaolin | Private | US Georgia kaolin producer |
Kaolin (Europe) | LB Minerals; Quarzwerke / Amberger Kaolinwerke | Private | European ceramic kaolin supply |
Kaolin (India) | Ashapura Minechem; English India Clays (EICL) | NSE/BSE | Regional producers in Traxys target markets |
Kaolin (Australia, junior) | Suvo Strategic Minerals | ASX: SUV | Australian kaolin producer/developer (Pittong, Victoria) |
Halloysite-kaolin (junior) | Latin Resources' former Noombenberry project (now under Pilbara Minerals ownership following 2025 acquisition — verify) | — | Peer halloysite-kaolin asset in WA |
HPA (incumbent) | Sumitomo Chemical; Sasol; Baikowski; Nippon Light Metal | Various | Established HPA producers using alkoxide/alum routes |
HPA (Australian developers) | Alpha HPA (ASX: A4N); FYI Resources (ASX: FYI); Altech Batteries (ASX: ATC); Impact Minerals (ASX: IPT) | ASX | Competing Australian HPA developers; Alpha HPA is materially more advanced (construction/production) |
Key Competitors
| Company | Revenue | Stage |
|---|---|---|
Andromeda Metals (FY2026) | A$0 | Pre-FID developer |
Imerys (FY2024) | ~€3.6bn (approximate; verify) | Major producer |
Alpha HPA (latest FY) | — | Building/producing HPA |
Suvo Strategic Minerals (latest FY) | — | Small producer |
Recent Developments
--



